HomeNewsBusinessSteelmakers want government to revisit duty, say local market can't absorb export volumes

Steelmakers want government to revisit duty, say local market can't absorb export volumes

Indian exporters were already facing pricing pressure when the government announced the export duty, which is aimed at curbing exports to boost domestic supply.

May 25, 2022 / 18:19 IST
Story continues below Advertisement

Indian steelmakers, facing pressure on their export margins after the government imposed a duty on a wide range of steel products shipped abroad, are hoping that the government will walk back its decision as the export volume is unlikely to be absorbed locally.

On May 22, India announced an increase in duty on exports of iron ore, up to 50 percent from 30 percent, and imposed an export duty of up to 15 percent on some steel intermediaries. Steel prices have rallied globally and almost doubled from their levels in March 2020.

Story continues below Advertisement

However, prices saw some correction in Europe and North America in April-May 2022. Indian exporters were already facing pricing pressure when the government announced the duty, aimed at curbing exports to boost domestic supply.

But industry experts believe that the domestic market does not have the appetite to absorb the exported volumes in the short-to-medium term.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show